Mediwound Ltd

NASDAQ MDWD

Download Data

Mediwound Ltd Market Capitalization on June 03, 2024: USD 156.61 M

Mediwound Ltd Market Capitalization is USD 156.61 M on June 03, 2024, a 84.08% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Mediwound Ltd 52-week high Market Capitalization is USD 182.91 M on May 01, 2024, which is 16.79% above the current Market Capitalization.
  • Mediwound Ltd 52-week low Market Capitalization is USD 66.10 M on September 08, 2023, which is -57.80% below the current Market Capitalization.
  • Mediwound Ltd average Market Capitalization for the last 52 weeks is USD 108.43 M.
NASDAQ: MDWD

Mediwound Ltd

CEO Prof. Lior Rosenberg M.D.
IPO Date March 20, 2014
Location Israel
Headquarters 42 Hayarkon Street, Yavne, Israel, 8122745
Employees 100
Sector Healthcare
Industry Biotechnology
Description

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Similar companies

ELYM

Eliem Therapeutics Inc

USD 8.34

8.17%

STRO

Sutro Biopharma

USD 4.10

-2.84%

AVTE

Aerovate Therapeutics Inc

USD 17.37

-0.46%

REPL

Replimune Group Inc

USD 5.44

3.23%

GLUE

Monte Rosa Therapeutics Inc

USD 3.98

-3.40%

NKTX

Nkarta Inc

USD 6.83

0.59%

GBIO

Generation Bio Co

USD 3.06

-3.77%

StockViz Staff

September 8, 2024

Any question? Send us an email